« Previous | Next » | All Messages |  EGEI Message Board Home | recommend post |  Ignore Poster

EGEI News eGene Inc. Will Exhibit at the Plant and Animal Genome XV Conference in San Diego, California, January 14-17, 2007

IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), developer of a revolutionary high-performance genetic analysis technology, announced today that it will exhibit at the Plant and Animal Genome XV Conference in San Diego, California, January 14-17, 2007.

The Plant and Animal Genome Conference will bring together the leading genetic scientists and researchers involved in plant and animal research and related areas. With over 50 countries represented, the Plant and Animal Genome Conference provides an established forum for the international and domestic exchange of information.

Ming S. Liu, CEO of eGene, noted in his announcement: "eGene will attend this meeting to introduce our technology. We believe our portable HDA-GT12(TM) genetic analyzer has potential for many important genotyping applications in plant and animal research laboratories. eGene represents a paradigm shift in the way that scientists think about genetic analysis, and our automatic, affordable, user-friendly genotyping system will be part of the future of DNA analysis."

eGene's Booth Number is 125.

About eGene Inc.

eGene developed the HDA-GT12(TM) (high-performance DNA analyzer for genotyping on 12 channels). The system analyzes the genetic fingerprints of living organisms. It performs fast DNA sample screening and high-resolution DNA fragment analysis (2-5bp). The system also analyzes the quality and quantity of RNA in gene expression market. The Company sells cartridges that are specific to the type of analysis to be performed. All data is then received in digital form for appropriate transmission and storage.

eGene Inc. (www.egeneinc.com) focuses its core technologies of capillary electrophoresis, liquid handling and automation to develop and manufacture low-cost microfluidic, miniaturized digital analyzer systems, software and consumables for biological materials testing applications. These products detect, quantify, identify and characterize biomolecules including DNA and RNA at high rates of specificity and sensitivity while automating routine and non-routine laboratory and industrial procedures critical to product safety, development quality and productivity.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors. The company undertakes no obligation to publicly release any revision, which may be made to reflect events or circumstances after the date hereof.